Last month our OpenTrials community manager Ben Meghreblian sat down to talk to AllTrials campaign manager Dr Till Bruckner about the public beta launch of OpenTrials. AllTrials (http://www.alltrials.net) campaigns for all clinical trials – past, present and future – to be registered, and their methods and results to be fully reported, and thus its work is […]
Read MoreHello fans of evidence-based medicine and open data! Following the recent launch of the OpenTrials public beta, Open Knowledge International’s Head of Technical Product Paul Walsh shares more information on the features that are available in the current beta release, and what is in the pipeline on the road to a proper v1 release. Features OpenTrials is designed as a modular platform, […]
Read MoreErick Turner, member of our OpenTrialsFDA team, recently talked to Jeppe Schroll about the importance of including data from regulatory agencies in systematic reviews. Jeppe Schroll has been interested in research methodology for 8 years and wrote his PhD on unpublished data and harms at the Nordic Cochrane Centre in Denmark. He has examined publicly […]
Read MoreSince our beta launch, we’ve had a steady stream of technical questions about how to use and interact with the data that powers OpenTrials. Good news! We have a beta public API available that will allow you to retrieve structured data about clinical trials listed in the OpenTrials database for using for your own projects, […]
Read MoreIt’s been quite a week – we were speaking at the International Open Data Conference in Madrid on Fri 7th, running a Hack Day in Berlin the following day, and then launching OpenTrials beta two days later at the World Health Summit. Now that the dust has settled, I wanted to give you a brief […]
Read MoreDr. Ben Goldacre shares news of the OpenTrials beta launch and provides further insights into why the team are releasing such an early prototype of the database. OpenTrials is a vast, ambitious project aiming to match all the publicly accessible documents and data, on all trials, side-by-side, in one place. You can read more about […]
Read MoreOpen Knowledge International is delighted to announce the launch of the public preview beta version of OpenTrials at a panel session on ‘Fostering Open Science in Global Health’ at the World Health Summit today, 10 October 2016, the world’s foremost forum for strategic questions of Global Health. OpenTrials is an open, online database of information […]
Read MoreErick Turner, M.D., is a psychiatrist-researcher and transparency advocate who is a member of the team behind OpenTrialsFDA, which aims to make the drug efficacy and safety data in the Food and Drug Administration’s (FDA) Drug Approval Packages much more readily usable. In this interview, he shares some of the background behind this work, as […]
Read MoreExciting news! OpenTrials will officially launch its beta on Monday 10th October 2016 at the World Health Summit in Berlin. After months of work behind-the-scenes meeting, planning, and developing, we’re all really excited about demoing OpenTrials to the world and announcing how to access and use the site! The launch will take place at the […]
Read MoreIn May, the OpenTrialsFDA team (a collaboration between Erick Turner, Dr. Ben Goldacre and the OpenTrials team at Open Knowledge) was selected as a finalist for the Open Science Prize. Working towards a first prototype in early December, OpenTrialsFDA will make the Drug Approval Packages (DAPs) from the FDA website easily accessible and searchable and […]
Read More